Abstract
Summary: Prilocaine–lidocaine emulsion (EMLA cream) is a topical anaesthetic commonly used prior to diagnostic and therapeutic procedures. While undergoing clinical investigation for the suspicion of a metabolic disorder, a series of children underwent skin biopsy with EMLA cream pretreatment. In each case, the pathologist identified ultrastructural features consistent with a lysosomal storage disorder, yet the clinical features were not consistent with the pathological findings. Ultrastructural artefact was suspected, resulting from the use of the EMLA cream. All patients underwent repeat skin biopsy without EMLA cream. Biopsies were reviewed by two pathologists blinded to the previous biopsy findings. Electron microscopy repeated without the use of EMLA cream was normal. It is concluded that the use of EMLA cream causes ultrastructural artefact and should be avoided prior to skin biopsy for electron microscopy.
Similar content being viewed by others
REFERENCES
de Waard-van der Spek FB, Mulder PG, Oranje AP (1997) Prilocaine/lidocaine patch as a local premedication for skin biopsy in children. J Am Acad Dermatol 37: 418–421.
Hoss DM, Gross EG, Grant-Kels JM (1999) Histopathology of an adverse reaction to a eutectic mixture of local anesthetics lidocaine and prilocaine. J Cutan Pathol 26: 100–104.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vallance, H., Chaba, T., Clarke, L. et al. Pseudo-lysosomal storage disease caused by EMLA cream. J Inherit Metab Dis 27, 507–511 (2004). https://doi.org/10.1023/B:BOLI.0000037352.98317.5a
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000037352.98317.5a